Market Data
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
PharmaCyte Biotech Inc. (NASDAQ:PMCB) shares skyrocketed 67.8% on Tuesday after the company announced it had completed the successful monetization of its stake in Femasys Inc. (NASDAQ:FEMY), significantly bolstering its liquidity.
The sale is projected to lift PharmaCyte’s combined cash and marketable securities to roughly $20 million, up from $13.3 million reported as of July 31, 2025. Management said the move demonstrates the strength of its capital allocation strategy while preserving a cautious approach to portfolio risk.
“Our successful monetization of the Femasys position demonstrates the effectiveness of our strategic and disciplined capital allocation approach,” said Josh Silverman, PharmaCyte Chief Executive Officer. “We are committed to deploying shareholder capital intelligently, balancing near-term returns with opportunities that can deliver sustained value creation.”
According to the company’s latest 10Q filing, PharmaCyte now holds about $25 million in marketable securities—on top of nearly $20 million in cash that includes proceeds from the divestiture. Prior to Tuesday’s rally, the stock had been trading around $0.65 per share, with approximately 6.8 million shares outstanding.
Looking ahead, PharmaCyte said it will continue searching for investments that enhance long-term shareholder value while maintaining disciplined operational execution.
PharmaCyte Biotech stock price
This content is for informational purposes only and does not constitute financial, investment, or other professional advice. It should not be considered a recommendation to buy or sell any securities or financial instruments. All investments involve risk, including the potential loss of principal. Past performance is not indicative of future results. You should conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Some portions of this content may have been generated or assisted by artificial intelligence (AI) tools and been reviewed for accuracy and quality by our editorial team.
Ford Motor Company (NYSE:F) has initiated a recall affecting 108,762 vehicles in the United States after regulators identified an issue involving the liftgate hinge covers, according to a notice from the National Highway Traffic Safety Administration (NHTSA). The agency said the recall, announced Friday, is intended to fix a defect in which the hinge cover […]
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
